Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis

被引:106
作者
Gales, Ana C.
Sader, Helio S.
Andrade, Soraya S.
Lutz, Larissa
Machado, Addo
Barth, Afonso L.
机构
[1] Univ Fed Sao Paulo, Lab Alerta, Sao Paulo, Brazil
[2] JMI Labs, N Liberty, IA USA
[3] Hosp Clin, Serv Patol Clin, Unidade Microbiol, Porto Alegre, RS, Brazil
关键词
Staphylococcus aureus; linezolid; drug resistance; cystic fibrosis;
D O I
10.1016/j.ijantimicag.2005.11.008
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We report the first linezolid-resistant Staphylococcus aureus strain isolated in Brazil. The strain was isolated from a 10-year-old female patient with cystic fibrosis (CF) who received repeated and prolonged courses of low-dose linezolid. The strain belonged to the Brazilian endemic methicillin-resistant S. aureus clone, and the G2576U mutation was identified in domain V of the 23S rRNA. Detection of this mechanism of resistance in a CF patient is very worrisome, as these patients may become a reservoir for further dissemination of resistant strains. Our findings emphasise the importance of optimal dosage of linezolid to prevent the emergence of resistance. (c) 2006 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:300 / 302
页数:3
相关论文
共 15 条
[1]  
[Anonymous], 38 SAN DIEG CA US IN
[2]  
[Anonymous], [No title captured]
[3]   Oxazolidinone antibiotics [J].
Diekema, DJ ;
Jones, RN .
LANCET, 2001, 358 (9297) :1975-1982
[4]  
*FDA, 2000, FDA APPR ZYV 1 ANT D
[5]   Linezolid pharmacokinetics in pediatric patients: an overview [J].
Jungbluth, GL ;
Welshman, IR ;
Hopkins, NK .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (09) :S153-S157
[6]   Linezolid for the treatment of community-acquired pneumonia in hospitalized children [J].
Kaplan, SL ;
Patterson, L ;
Edwards, KM ;
Azimi, PH ;
Bradley, JS ;
Blumer, JL ;
Tan, TQ ;
Lobeck, FG ;
Anderson, DC .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (05) :488-494
[7]   Single dose pharmacokinetics of linezolid in infants and children [J].
Kearns, GL ;
Abdel-Rahman, SM ;
Blumer, JL ;
Reed, MD ;
James, LP ;
Jacobs, RF ;
Welshman, IR ;
Jungbluth, GL ;
Stalker, DJ .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (12) :1178-1184
[8]   Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center [J].
Kloss, P ;
Xiong, LQ ;
Shinabarger, DL ;
Mankin, AS .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 294 (01) :93-101
[9]   Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA [J].
Meka, VG ;
Pillai, SK ;
Sakoulas, G ;
Wennersten, C ;
Venkataraman, L ;
DeGirolami, PC ;
Eliopoulos, GM ;
Moellering, RC ;
Gold, HS .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (02) :311-317
[10]  
Paterson DL, 2003, ANN INTERN MED, V139, P863, DOI 10.7326/0003-4819-139-10-200311180-00017